Author:
Ding Hongyun,Dong Ying,Deng Yan,Xu Yanchun,Liu Yan,Wu Jing,Chen Mengni,Zhang Canglin,Zheng Weibin
Abstract
Abstract
Background
Chloroquine (CQ) has been the preferred clinical treatment for vivax malaria in Yunnan Province since 1958, with over 300,000 patients. This study aimed to help make trend predictions regarding variations the in anti-malarial drug susceptibility of Plasmodium vivax distributed in Yunnan Province and effectively implement monitoring measures on the efficacy of anti-malarial drugs for vivax malaria.
Methods
Blood samples collected from patients with mono-P. vivax infections were employed in this study based on the principle of cluster sampling. The whole gene of P. vivax multidrug resistance 1 protein gene (pvmdr1) was amplified by nested-PCR techniques and the PCR amplification produce were sequenced by Sanger bidirectional sequencing. The mutant loci and haplotypes of coding DNA sequence (CDS) were identified by comparison with the reference sequence (NC_009915.1) of the P. vivax Sal I isolate. Parameters such as Ka/Ks ratio were calculated using MEGA 5.04 software.
Results
A total of 753 blood samples from patients infected with mono-P. vivax were collected, of which 624 blood samples yielded the full gene sequence (4392 bp) of the pvmdr1 gene, with 283, 140, 119, and 82 sequences from 2014, 2020, 2021 and 2022, respectively. A total of 52 single nucleotide polymorphic (SNP) loci were detected for the 624 CDSs, of which 92.3% (48/52), 34.6% (18/52), 42.3% (22/52), and 36.5% (19/52) SNPs were detected in 2014, 2020, 2021 and 2022, respectively. All of 624 CDSs were defined for a total of 105 mutant haplotypes, with CDSs of 2014, 2020, 2021, and 2022 containing 88, 15, 21, and 13 haplotypes, respectively. Of the 105 haplotypes, the threefold mutant haplotype (Hap_87) was the starting point for stepwise evolution, and the most drastic tenfold mutations were Hap_14 and Hap_78, and the fivefold, sixfold, sevenfold, and eightfold mutations.
Conclusions
In the majority of vivax malaria cases in Yunnan Province, most of them were infected with strains carrying demonstrating highly mutated in pvmdr1 genes. However, the dominant mutation strains types varied from year to year, which warrants further exploration in order to confirm the correlation between with phenotypic changes in P. vivax strains and their susceptibility to anti-malarial drugs such as chloroquine.
Funder
National Science Foundation, Chian
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference64 articles.
1. Wellems TE, Plowe CV. Chloroquine-resistant malaria. J Infect Dis. 2001;184:770–6.
2. Yang HL, Yang PF, Li XL, Gao BH, Zhang ZY, Yang YM. Changes of chloroquine resistance of Plasmodium falciparum in Yunnan Province (in Chinese). J Pathog Biol. 2005;5:54–6.
3. Payne D. Spread of chloroquine resistance in Plasmodium falciparum. Parasitol Today. 1987;3:241–6.
4. Che LG, Chen WC, Yang HL. [Investigation on geographical distribution of chloroquine-resistant strains of falciparum malaria in Yunnan Province] (in Chinese). Chin J Parasitol Parasit Dis. 1991;12:31–3.
5. Yang HL, Yang PF, Dong Y, Che LG, He H, Liu DQ, et al. [Longitudinal monitoring of chloroquine resistance of Plasmodium falciparum in Yunnan Province] (in Chinese). Chin J Parasitol Parasit Dis. 1994;1:33–5.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献